Integrated Diagnostics Holdings plc (LON: IDHC)
London
· Delayed Price · Currency is GBP · Price in USD
0.396
+0.016 (4.08%)
Nov 22, 2024, 2:58 PM BST
IDHC Revenue
Integrated Diagnostics Holdings had revenue of 1.33B EGP in the quarter ending June 30, 2024, with 38.74% growth. This brings the company's revenue in the last twelve months to 4.75B, up 34.79% year-over-year. In the year 2023, Integrated Diagnostics Holdings had annual revenue of 4.12B with 14.35% growth.
Revenue (ttm)
4.75B EGP
Revenue Growth
+34.79%
P/S Ratio
2.40
Revenue / Employee
709.56K EGP
Employees
6,692
Market Cap
183.75M GBP
Revenue Chart
* This company reports financials in EGP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
Dec 31, 2020 | 2.66B | 429.77M | 19.30% |
Dec 31, 2019 | 2.23B | 305.04M | 15.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 38.20B |
GSK plc | 31.31B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.46B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 76.10M |